Study identifier:D3250R00059
ClinicalTrials.gov identifier:NCT04221802
EudraCT identifier:N/A
CTIS identifier:N/A
A multicentre single arm observational prospective study to assess demographic characteristics burden of disease PRO’s in uncontrolled, severe eosinophilic asthma patients aged 18y or older and qualifying for treatment with benralizumab in BE
Severe Asthma
N/A
No
-
All
76
Observational
18 Years - 99 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: -
Verified 01 May 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|